Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod ...
Researchers are looking for new ways to help the body adapt to disrupted circadian rhythms and jet lag. A new study points to a possible solution.